Partner news
News
Partner news
Fusion Pharmaceuticals Completes Oversubscribed Series A Financing Totaling $46 Million USD to Develop Targeted Alpha Therapeutics
Read full storyPartner news
Provention Bio Announces Licensing Agreements with Janssen for Two Clinical-Stage Immunology Assets
Read full storyPartner news
Accelerator Corporation Announces Series A Financing in Rodeo Therapeutics to Focus on Small-Molecule Regenerative Therapies
Read full storyPartner news
BlackThorn Therapeutics Enrolls First Patient in Phase 2a Study of Lead Compound, BTRX-246040, in Major Depressive Disorder
Read full storyPartner news
E-Scape Bio Series A Extension Brings Total Round to $63 Million to Fund Neurodegenerative Disease Pipeline
Read full storyPartner news
Provention Bio, Inc. Appoints Eleanor L. Ramos, MD, as Chief Medical Officer and Chief Operating Officer
Read full storyPartner news
Provention Bio, Inc. Secures $28.4 Million Founding Financing to Fund Development Targeting the Interception and Prevention of Immune-Mediated Disease
Read full storyPartner news
Aelix Therapeutics appoints HIV expert as CMO
Read full storyPartner news
FACIT-Seeded Fusion Pharmaceuticals Closes US$25M Series A Led by Johnson & Johnson Innovation
Read full storyPartner news
Ethicon Announces Agreement to Acquire Torax Medical, Inc.
Read full storyPartner news
Verb Surgical Delivers Digital Surgery Prototype Demonstration to Collaboration Partners
Read full storyPartner news